Keywords: nowotwory mieloproliferacyjne; mutacje JAK2; mutacja JAK2 V617F; czerwienica prawdziwa; nadpÅytkowoÅÄ samoistna; Myeloproliferative neoplasm; JAK2 mutation; JAK2 V617F mutation; Polycythemia vera; Essential thrombocythemia;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Ischemic stroke; essential thrombocythemia; JAK2 V617F mutation; antiplatelet therapy; cytoreductive therapy;
Keywords: 5q minus; JAK2 V617F mutation; RARS-T; MDS; Lenalidomide
Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm
Keywords: All cerebrovascular disease/Stroke; Risk factors in epidemiology; Clinical trials observational study (cohort, case control); JAK2 V617F mutation; Myeloproliferative neoplasm;
Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation
Keywords: Acute myeloid leukemia; blastic plasmacytoid dendritic cell neoplasm; MYC; JAK2 V617F mutation
The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms
Keywords: Myeloproliferative neoplasms; Molecular markers; JAK2 V617F mutation; JAK2 exon 12 mutation; MPL W515L mutation; MPL W515K mutation; CAL-R mutations
Zaburzenia hemostazy w czerwienicy prawdziwej i nadpÅytkowoÅci samoistnej
Keywords: czerwienica prawdziwa; nadpÅytkowoÅÄ samoistna; zakrzepica; krwawienia; mutacja JAK2 v617F; Polycythemia vera; Essential thrombocythemia; Thrombosis; Bleeding; JAK2 V617F mutation;
Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway
Keywords: Cdk4; cyclin-dependent kinase 4; DCFH; dichlorodihydrofluorescein; DMSO; dimethyl sulfoxide; Epo; erythropoetin; ERK; extracellular signal-regulated kinase; FBS; fetal bovine serum; i.p.; intraperitoneal; i.v.; intravenous; Jak; Janus kinase; JNK; c-Jun N
Diagnosis of chronic myeloproliferative neoplasms with special emphasis on early stages
Keywords: bone marrow features; chronic myeloproliferative neoplasms; essential thrombocythaemia; JAK2 V617F mutation; myelofibrotic transformation; myeloid metaplasia; polycythaemia vera; primary myelofibrosis; prodromal stages; prognosis
Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies
Keywords: Childhood ET; Epo hypersensitivity; Clonality; JAK2 V617F mutation;
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF)
Keywords: Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Myeloid metaplasia; Myelofibrosis; Erythropoietin; Endogenous erythroid colony assay; JAK2 V617F mutation; Bone marrow pathologyThrombocytémie; Polyglobulie; JAK2; Biopsie médulll